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Endoglin (CD105) is expressed on the surface of endothelial and haematopoietic cells in mammals and binds TGFb isoforms
and 3 in combination with the signaling complex of TGFb receptors types I and II. Endoglin expression increases during
angiogenesis, wound healing, and inflammation, all of which are associated with TGFb signaling and alterations in vascular
structure. The importance of endoglin for normal vascular architecture is further indicated by the association of mutations
in the endoglin gene with the inherited disorder Hereditary Haemorrhagic Telangiectasia Type 1 (HHT1), a disease
characterised by bleeding from vascular malformations. In order to study the role of endoglin in vivo in more detail and to
work toward developing an animal model of HHT1, we have derived mice that carry a targeted nonsense mutation in the
endoglin gene. Studies on these mice have revealed that endoglin is essential for early development. Embryos homozygous
for the endoglin mutation fail to progress beyond 10.5 days postcoitum and fail to form mature blood vessels in the yolk sac.
This phenotype is remarkably similar to that of the TGFb1 and the TGFb receptor II knockout mice, indicating that
ndoglin is needed in vivo for TGFb1 signaling during extraembryonic vascular development. In addition, we have observed
cardiac defects in homozygous endoglin-deficient embryos, suggesting endoglin also plays a role in cardiogenesis. We
anticipate that heterozygous mice will ultimately serve as a useful disease model for HHT1, as some individuals have
dilated and fragile blood vessels similar to vascular malformations seen in HHT patients. © 2000 Academic Press
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aINTRODUCTION
Endoglin (CD105) is a transmembrane glycoprotein ex-
pressed by mammalian vascular endothelial cells, where it
is found associated with TGFb signaling receptors (Cheifetz
et al., 1992). The minimum TGFb receptor complex re-
quired for signaling contains only the type I and II trans-
membrane receptors. These control the expression of
TGFb-responsive genes by ligand-activated phosphoryla-
1 To whom correspondence should be addressed at School of
Biochemistry and Genetics, Medical School, University of New-
castle upon Tyne, NE2 4HH, UK. E-mail: helen.arthur@ncl.ac.uk.2 Current address: Papworth Hospital, Cambridge CB3 8RE, UK.
42ion of SMAD proteins, which then move into the nucleus
Heldin et al., 1997; Massague, 1998). However, coexpres-
ion of ancillary nonsignaling receptors, such as endoglin,
nfluence which TGFb isoforms are bound and which
signaling responses are made. In this regard, endoglin pref-
erentially binds TGFb isoforms 1 and 3, when associated
with TbRII, the TGFb type II receptor (Barbara et al., 1999),
and overexpression of endoglin in cell lines attenuates some
responses to TGFb1 (Lastres et al., 1996; Letamendı´a et al.,
998). The degree to which this ancillary role of endoglin is
requirement for TGFb signaling in vivo has not previously
been studied. Recently, endoglin has also been shown to
bind, in vitro, at least three other members of the TGFb
superfamily (Activin A, BMP-2 and BMP-7 ) and to interact
0012-1606/00 $35.00
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43Endoglin Is Required for Extraembryonic Angiogenesiswith the activin type II receptors (ActRII and ActRIIB), and
so may be involved in a number of different signaling
pathways (Barbara et al., 1999).
TGFb1 signaling is important for normal vascular devel-
pment. It is involved in the differentiation of recruited
mooth muscle cells by the endothelial cells in the early
tages of vasculogenesis and also plays a critical role in
ngiogenesis (Folkman and D’Amore, 1996; Pepper, 1997).
ice homozygous for targeted mutations of the TGFb1
gene exhibit severe deficiencies in haematopoiesis and
vasculogenesis in the yolk sac and die around 10.5 days
postcoitum (dpc) (Dickson et al., 1995). A similar pheno-
ype is exhibited by mice lacking TbRII (Oshima et al.,
996). In contrast, deficiencies of either TGFb2 or TGFb3
re compatible with development to birth, although both
esult in perinatal death (Kaartinen et al., 1995; Proetzel et
al., 1995; Sanford et al., 1997). These phenotypes suggest
that binding of TGFb1 to a receptor complex containing the
TbRII subunit leads to critical signaling events required for
haematopoiesis and vasculogenesis in the yolk sac.
Humans, heterozygous for deleterious mutations in the
endoglin gene, develop the disease Hereditary Haemor-
rhagic Telangiectasia Type 1 (HHT1) (McAllister et al.,
1994), an autosomal dominant disease characterised by
small, localised vascular malformations called telangiecta-
ses, which develop in the nasal septum, oral mucosa, and
gastrointestinal tract, and are prone to prolonged bleeding
episodes (Guttmacher et al., 1995; Shovlin et al., 1997).
Larger arterio-venous malformations may also develop at
pulmonary, hepatic, and cerebral sites with potentially fatal
consequences. HHT1 patients have an overall 50% reduc-
tion in the basal level of endoglin expression on vascular
endothelium, demonstrating that normal levels of endoglin
protein are important in maintaining vascular structure,
but the specific molecular events which cause the vascular
malformations are not yet understood (Pece et al., 1997).
Interestingly, defects in Alk1, a type I receptor of the
TGFb receptor family, which appears to signal through
SMAD1, result in a clinically similar form of HHT (Johnson
et al., 1996), suggesting that endoglin and Alk1 act in the
same signaling pathway. The similar expression pattern of
ALK1 and endoglin in the vascular endothelium is consis-
tent with this suggestion (Panchenko et al., 1996; Roelen et
al., 1997).
In order to study the role of endoglin in vivo in more
detail and to work toward developing an animal model of
HHT1, we have introduced a targeted stop codon, similar to
some mutations found in HHT1 patients (McAllister et al.,
1995), into the murine endoglin gene (Fig. 1). We report here
our preliminary analysis of these mice.
MATERIALS AND METHODS
Construction of the targeting vector and generation of chimeric
mice. Genomic clones containing the endoglin gene were isolated
from a mouse strain 129/Ola lambda library by probing with the
0.43-kb BamH1/BspH1 fragment spanning exons 6 and 7 of murine o
Copyright © 2000 by Academic Press. All rightendoglin from clone pCDNA1-7/18 (Ge and Butcher, 1994). Lin-
earised targeting construct DNA (Fig. 1A) was added to 1.2 3 108
E14Tg2a embryonic stem (ES) cells (from mouse strain 129/Ola)
and exposed to a 0.8 kV, 3.0 mF pulse in a BioRad gene pulser. Cells
were plated out at 5 3 106 cells/10-cm petri dish. Recombinant
lones were selected after 1 day by the addition of G418 (at a final
oncentration of 150 mg/ml) and gancyclovir (at a final concentra-
ion of 0.1%) for a total of 8 days. Clones containing the targeted
eletion of the central portion of the endoglin gene were identified
y Southern blotting, using two probes external to the targeting
ragment. Eight positive clones out of 60 recombinant ES clones
ested were then confirmed by Southern blotting with a third probe
erived from the neomycin gene to ensure that only single integra-
ion events had occurred (Fig. 1B). Chimeric males were derived
rom injection of three independent ES clones into blastocysts of
.5 dpc C57Bl/6J mice implanted into pseudopregnant foster fe-
ales 2.5 dpc. Five out of seven male chimeras gave 100%
erm-line transmission of ES-derived 129/Ola genes, detected by
he agouti coat colour of the progeny. The endoglin genotype of the
ice was assessed either by Southern blotting (Fig. 1C) or by PCR
sing template DNA prepared from tail biopsies.
Timed matings and characterisation of offspring. All the
nalyses reported here have been performed on mice from a mixed
29/Ola and C57Bl/6J genetic background. Embryos were collected
t various intervals from females following timed matings between
eterozygous (eng1/2) mice, where noon of the day of the vaginal
plug was taken as 0.5 day. Embryos and yolk sacs were dissected
from the decidua and examined under the microscope. For geno-
typing, DNA was isolated from yolk sacs of embryos or from tail
biopsies of 3-week-old anaesthetised mice by digesting with 0.2
mg/ml proteinase K in tail lysis buffer (100 mM Tris-HCl, pH 8.5,
5 mM EDTA, 0.2% SDS, 200 mM NaCl) overnight at 55°C (Laird et
al., 1991). DNA was precipitated with isopropanol, washed with
70% ethanol, and dissolved in TE buffer (10 mM Tris-HCl, 1 mM
EDTA, pH 7.5).
For routine genotyping, PCR contained two primer pairs simul-
taneously. For the neo gene, primers were d(ACGTACTCGGAT-
GGAAGCC) and d(CAAGCTCTTCAGCAATATCACG); to detect
the wild type endoglin gene, primers from the region deleted in the
mutant allele were used, d(ACCATCTTGTCCTGAGTAGCG) and
d(TGAGCCTGACGGGAAACTG). Annealing temperature was
58°C and 30 cycles were used for tail DNA while 35 cycles were
used for the less concentrated yolk sac DNA. PCR products were
resolved on 1.5% agarose gels.
Total protein was isolated from embryos and separated by
SDS-PAGE. Endoglin was detected by Western blotting using
anti-endoglin antibody (Pharmingen). Total RNA for rtPCR was
prepared using Trizol (Life Technologies).
X-gal staining, histology, and immunohistochemistry. Em-
bryos or small pieces of adult tissue were lightly fixed in 2.5%
paraformaldehyde in PBS, washed three times in PBS, and stained
for b-galactosidase activity by incubating overnight at 30°C in 3
mM potassium ferricyanide, 3 mM potassium ferrocyanide, 10 mM
sodium phosphate buffer, pH 7.3, 15 mM sodium chloride, 1 mM
magnesium chloride, and 2 mg/ml X-gal. X-gal-stained and un-
stained tissues were fixed in 4% formaldehyde/PBS at room tem-
perature, washed in PBS, dehydrated through ethanol, cleared in
histoclear, and embedded in paraffin fibrowax. Sections (4 mm)
ere lightly counterstained with eosin or stained with haematoxy-
in and eosin or elastin van Gieson according to standard proce-
ures. For immunohistochemistry, antigen retrieval was carried
ut by incubation with 0.1% trypsin in 0.1% CaCl2 (pH 7.6) at
s of reproduction in any form reserved.
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44 Arthur et al.FIG. 1. Targeted disruption of the endoglin gene in ES cells and mice. (A) Wild-type endoglin gene, targeting construct and targeted allele.
ndoglin exons (boxed regions) and introns are drawn approximately to scale. In the targeting construct a deletion of approximately 5-kb
ndoglin DNA, including exons 9a, 9b, 10, and 11, means that PCR primers from exons 9a and 9b can be used to detect the wild-type allele.
he b-gal/neo cassette has a promoterless lacZ gene immediately downstream of an IRES site, allowing transcription driven by the endoglin
promoter to be measured using b-galactosidase. The MC1neo gene driven by the Tk promoter and F9 enhancer enabled selection for
integration of the construct. Two copies of the Tk gene from HSV were used for selection against nonhomologous recombination events.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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45Endoglin Is Required for Extraembryonic Angiogenesis37°C for 18 min. Endogenous peroxidase was quenched in hydrogen
peroxide and immunohistochemical staining was carried out using
the Histomouse-SP kit (Zymed Laboratories) using antibodies
raised against human fibronectin, smooth muscle actin, or Von
Willebrand factor (all from DAKO).
RESULTS
Targeted Disruption of the Endoglin Gene Causes
Embryonic Lethality
The targeting construct used to disrupt the endoglin gene
had the following features: (1) a premature stop codon was
introduced into the BspH1 site in exon 8 of the endoglin
gene with the expected effect of producing a truncated
endoglin protein; (2) this stop codon was immediately
preceded by an influenza haemagglutinin (HA) epitope to
facilitate immunological detection of the truncated prod-
uct; (3) the lacZ coding region of Escherichia coli with an
internal ribosome entry site was positioned immediately
downstream of the endoglin mutation, so that expression
from the endoglin promoter could also be monitored using
b-galactosidase; and (4) a deletion of exons 9, 10, and 11 was
introduced to minimise the chances of producing a func-
tional endoglin molecule (Fig. 1A). Full-length endoglin
protein was not present in eng2/2 embryos showing that the
endoglin gene had been successfully disrupted during tar-
geted mutagenesis (Fig. 1D). However, we were unable to
detect the expected truncated protein of 37 kDa, indicating
it may be unstable, as has also been reported for HHT1
(B) Southern blot analysis of two clones (67 and 78) of double-res
dditional EcoR1 (R1) sites, which are used to differentiate betwee
NA digested with EcoR1 and probed with 39 and 59 genomic probe
o the wild-type 16-kb fragment. The right panel shows the same d
nalysis of agouti progeny of a germ-line chimera probed with th
utant endoglin allele. (D) Western blot of reduced endoglin prote
lack full length endoglin protein. (E) rtPCR of total RNA from eng1
boundaries show that a 129-bp PCR product corresponding to exon
genotypes, while the 199- and 175-bp PCR products corresponding t
TABLE 1
Analysis of Progeny from Heterozygote (eng1/2) Intercrosses
Age
Genotype
1/1 1/2 2/2
3 weeks postpartum 42 (25) 58 (50) 0 (25
Embryo (9.5 dpc) 25 (26.75) 56 (53.5) 26 (26
Note. Observed numbers of progeny of each genotype are in bold
arentheses.embryos.
Copyright © 2000 by Academic Press. All rightatients (Gallione et al., 1998; Pece et al., 1997). As ex-
ected, exons 5 (not shown), 6, and 7 were transcribed in
ndoglin-deficient (eng2/2) progeny whereas exons 10 and 11
were not transcribed, as shown by rtPCR (Fig. 1E).
Crosses between animals which were heterozygous for
this mutant allele of endoglin (eng1/2) yielded very low
litter sizes (typically 4 or 5 pups) and no homozygous eng2/2
pups have been born among the 100 progeny tested to date.
This clearly indicates that the endoglin mutation is lethal
in the homozygous state (see Table 1). To determine at
which stage of development the eng2/2 embryos died, het-
rozygous (eng1/2) females from timed matings with eng1/2
males were euthanised at various stages of pregnancy. Yolk
sacs were then examined prior to use for DNA preparation
and retrospective genotyping. It became clear that when
embryo progeny are examined at 9.5 dpc, the observed
number of homozygous mutants is at the expected Mende-
lian frequency (Table 1), but by 10.5 dpc all eng2/2 embryos
had died and were in the process of being reabsorbed.
eng2/2 Embryos Show Severe Defects in
Haematopoiesis and Angiogenesis of the Yolk Sac
At 9.5 dpc, the most striking features of the eng2/2
embryos were the abnormal vasculature and anaemia of the
yolk sac (Fig. 2A). Endoglin appeared to be essential for the
formation of mature vessels in the extraembryonic vascu-
lature. When endoglin expression was assessed using
b-galactosidase transcribed from the endoglin promoter in
the mutant allele, it was seen in the endothelium of the
t ES cells. Introduction of the b-gal/neo cassette results in three
targeted and the wild-type alleles. The left panel shows genomic
hich reveal novel 8- and 4.5-kb fragments, respectively, in addition
ts probed with DNA derived from the neo gene. (C) Southern blot
robe. As before, the 8-kb EcoR1 fragment is associated with the
om eng1/1, eng1/2, and eng2/2 embryos shows that eng2/2 embryos
eng2/2 embryos. Primers designed to amplify cDNA across intron
d 7 was amplified from the cDNA prepared from embryos of both
ns 10 and 11 were only amplified from cDNA prepared from eng1/1
Total x2 Probability
100 37.84 !0.001 (2 df )
107 0.252 Not significant (almost perfect fit)
and expected numbers, based on the Mendelian ratio 1:2:1, are inistan
n the
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47Endoglin Is Required for Extraembryonic Angiogenesisnewly formed yolk sac vessels of eng1/2 embryos (Fig. 2B),
ut only in isolated cells in many of the eng2/2 yolk sacs
Fig. 2C). Upon closer examination, there were fewer and
ess well-developed vascular channels and dramatically
educed numbers of red blood cells in the yolk sac of many
ng2/2 embryos (Fig. 2E) compared with wild-type or eng1/2
embryos (Fig. 2D), indicating defects in yolk sac haemato-
poiesis. However, this was not always the case, as distended
vascular channels which contained large numbers of blood
cells also occurred in eng2/2 yolk sacs (Fig. 2G). Histological
sections of yolk sac were immunostained for fibronectin, an
extracellular matrix protein whose expression is regulated
by TGFb1 signaling and modulated by endoglin (Lastres et
l., 1996). Fibronectin expression was not quantified, but
id not appear to be significantly altered in eng2/2 compared
with eng1/2 or wild-type embryos and was clearly seen in
the subendothelium of the yolk sac of all three genotypes
(Figs. 2F and 2G).
eng2/2 Embryos Exhibit Defects in Cardiogenesis
Overall the eng2/2 embryos were much more fragile and
smaller than their wild-type and heterozygous littermates
(Fig. 3). Many exhibited developmental delay of about 0.5
day, which may have been due to yolk sac insufficiency and
this may have been the reason for the delayed fusion of the
dorsal aorta seen in eng2/2 embryos. However, in contrast to
he severe vascular defects seen the yolk sac, the appear-
nce of the vasculature of the eng2/2 embryos was largely
normal, including development of the capillary network in
most cases (Fig. 3). Exceptions included occasional embryos
with a reduced cephalic capillary bed (Fig. 3B). There was
severe anaemia and reduced red cell count in nearly all
cases, presumably due to the reduced levels of haematopoi-
esis in the yolk sac, the main source of embryonic red blood
cells at this stage in development (Dzierzak and Medvin-
sky, 1995). In addition, many of the eng2/2 embryos had
evidence of abnormal cardiac development. Almost all had
enlarged ventricles (Fig. 4B) and very dilated outflow tracts
(Figs. 4D and 4F). The endothelial surface of the truncal
cushions failed to organise in about half the eng2/2 embryos
(Fig. 4D). No difference in fibronectin expression in endo-
cardial cushions was seen between eng1/1 and eng2/2 em-
bryos, indicating that endoglin is not required for fibronec-
tin expression in the cardiac jelly (Figs. 4E and 4F).
FIG. 2. Analysis of the yolk sac of 9.5 dpc embryos. (A)Whole mo
cells in the eng1/1 yolk sac (which is also seen in eng1/2 yolk sac
Detection of endoglin expression using X-gal staining shows endog
whereas it is associated with isolated cells in the eng2/2 yolk sac (C
was the only normal vessel seen in eng2/2 yolk sacs. Histological a
Haematoxylin and eosin-stained sections of yolk sac showed norm
eng1/2 yolk sac (D), but poor differentiation of vessels typical of
fibronectin show this protein associated with both endothelial lay
e, endothelial cell; en, endoderm; x, undifferentiated vessel. Scale bars;
Copyright © 2000 by Academic Press. All rightowever, endoglin was expressed by individual migrating
esenchymal cells of the endocardial cushion (Fig. 4G), but
hese cells were rarely seen in eng2/2 embryos. In addition,
many of the eng2/2 embryos had abnormal cardiac looping
and exhibited pericardial effusion (Figs. 3C and 3D).
FIG. 3. Whole mount 9.5 dpc embryos stained with X-gal showing
endoglin expression associated with the developing vasculature.
The genotype of each embryo is indicated on the figure and an
arrow points to the cephalic capillary bed in the eng1/2 embryo.
Scale bar: (A, B, C, D) 1 mm.
iew of yolk sacs showing an extensive vasculature full of red blood
ut no vessels and very few red blood cells in the eng2/2 yolk sac.
ssociated with the newly formed vessels in the eng1/2 yolk sac (B),
the umbilical vessel (folded flat beneath the yolk sac in this view)
is of yolk sacs from eng1/2 (D and F) and eng2/2 (E and G) embryos.
evelopment of vascular channels containing red blood cells in the
e regions of the eng2/2 yolk sac (E). Sections immunostained for
the yolk sacs of eng1/2 (F) and eng2/2 embryos (G). bc, blood cells;unt v
s), b
lin a
) and
nalys
al d
larg
ers of
(A) 1 mm; (B, C) 400 mm; (D, E, F, G) 50 mm.
s of reproduction in any form reserved.
D48 Arthur et al.FIG. 4. Examination of heart development in 9.5 dpc embryos illustrated by sagittal sections of eng1/2 (A, C, E, G, and H) and eng2/2 (B,
D, and F) embryos. Haematoxylin and eosin-stained sections through primitive ventricle (A and B) showing no red blood cells in the
ventricular lumen, dilated ventricle, and thinner myocardium in the eng2/2 embryo (B). X-gal-stained sections through outflow tract (C and) show strong endoglin expression in the organising heart tissue of the eng1/2 embryo (C), while the eng2/2 embryo shows ill-formed
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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49Endoglin Is Required for Extraembryonic AngiogenesisEndoglin Expression in Vascular Endothelium
Is Heterogeneous
In 9.5 dpc eng1/2 embryos, endoglin expression can be
seen in the endothelial cells throughout the developing
vascular system and is strongest in the endocardium (Fig.
IG. 5. Examination of endoglin expression in adult heart and lun
xpression particularly on the pulmonary artery side of the valve. M
ith the capillary network supplying the cardiac muscle. (C and
mmunostained brown for von Willebrand factor. (C) Strong endo
hile weaker expression is associated with stromal cells within th
actor and endoglin is seen in the capillary endothelium (short ar
essels particularly veins (long arrows). Scale bar: 100 mm. h, hear3A). We compared endoglin expression with that of another o
ndocardial cushion; l, lumen of outflow tract; m, myocardial cells; vl,
Copyright © 2000 by Academic Press. All rightndothelial marker, von Willebrand factor, and found that
arger embryonic vessels express both endoglin and von
illebrand factor (e.g., dorsal aorta and branchial arch
rteries), but endocardial cells expressed endoglin alone and
e located a junction of expression of von Willebrand factor
n the aortic sac region of the outflow tract (Fig. 4H). This
sue. Pulmonary valve, stained with X-gal (A), shows high endoglin
dium, stained with X-gal (B), shows endoglin expression associated
djacent sections of lung, stained with X-gal (blue) and eosin and
expression is seen in alveolar capillary endothelial cells (arrows),
lmonary interstitium. (D) Some colocalisation of von Willebrand
), but von Willebrand factor is mainly associated with the larger
valve; a, pulmonary artery.g tis
yocar
D) A
glin
e pubservation is in agreement with previous data showingndocardial cells (D). Sections through outflow tract, immunostained (brown) for fibronectin, show expression in truncal cushions of both
ng1/2 (E) and eng2/2 (F) embryos. X-gal and eosin-stained section through a central portion of the developing heart (G) shows endoglin
xpression (blue) associated with mesenchymal cells within the endocardial cushion. X-gal and von Willebrand factor-stained section
hrough the heart (H) showing endoglin expression throughout the endocardium while von Willebrand factor (brown) is associated only
ith the endothelium of the aortic sac region of the outflow tract. Scale bar: (A,B,G) 100 mm; (C,D,E,F,H) 50 mm. e, endothelial cells; ec,lumen of primitive ventricle.
s of reproduction in any form reserved.
50 Arthur et al.FIG. 6. Comparison of blood vessels in age-matched eng1/2 and eng1/1 mice. Convoluted and dilated blood vessel seen in the abdominal
skin of an eng1/2 mouse (B) compared with normal vasculature from a similar region of skin from an eng1/1 mouse (A). Transverse sections
of these vessels stained with elastin van Gieson show the sparse and uneven distribution of elastin fibres (stained black) in the abnormal
dilated vessel from the eng1/2 mouse (D) compared with a normal venule in C. The arrow in D points to a region of vessel rupture which
probably occurred when the skin was removed from the animal and serves to illustrate the fragility of this vessel. Immunohistochemical
staining for smooth muscle actin (stained brown) shows disorganised smooth muscle cells surrounding the abnormal vessel in the eng1/2
mouse (F) compared with the normal vessels in E. Scale bars: (A, B) 500 mm, (C, D, E, F) 25 mm.
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51Endoglin Is Required for Extraembryonic Angiogenesisthat expression of von Willebrand factor is limited to the
larger vessels at this stage in development (Coffin et al.,
1991) and illustrates differences between endothelial cells
from different regions of the vasculature.
In adult mice, endoglin expression is much more exten-
sive. It is associated with both endothelial and stromal
tissue (St-Jacques et al., 1994) and to a lesser extent with
smooth muscle cells (Adam et al., 1998). We have focused
our analysis on expression in heart and lung tissue. In heart,
the highest endoglin expression was seen in the aortopul-
monary and atrioventricular valves and was associated with
the valve mesenchymal cells (Fig. 5A). Expression is also
seen in the endothelium of small blood vessels in the
compact layers of the ventricular walls but not in the outer
layer of the myocardium (Fig. 5B). In the lung, endoglin was
expressed in some stromal cells within the interstitium and
in most endothelial cells of the vasculature, but was par-
ticularly high in the pulmonary microcapillaries (Fig. 5C).
Von Willebrand factor was expressed in a complementary
fashion in the pulmonary vasculature, strongly staining
large vessel endothelium (Fig. 5D), but weakly staining the
microvasculature, in agreement with previous reports
(Yamamoto et al., 1998).
Mice, Heterozygous for the Endoglin Mutation,
Sometimes Have Abnormal and Dilated
Blood Vessels
Occasional mice, of strain 129/Ola, carrying a single copy
of the endoglin mutation exhibited extensive dilated and
weak-walled vessels typical of HHT. One such example is
shown in Fig. 6. A large vessel, which appeared to be
venous, was extremely dilated and somewhat convoluted
(Fig. 6B). Detailed examination showed that the elastin
support fibres (Fig. 6D) and smooth muscle cells (Fig. 6F)
surrounding this vessel were both disorganised and sparsely
distributed, properties which may contribute to the fragility
of these vessels.
DISCUSSION
This work clearly shows that expression of endoglin is
essential during angiogenesis in the yolk sac during early
development. The phenotype of the endoglin knockout
mouse is very similar to the TbRII knockout mice (Oshima
et al., 1996) and to the fraction of TGFb1 knockout mice,
hich die in utero (Dickson et al., 1995). This contrasts
with the less severe phenotype of mice without TGFb2 or
TGFb3 (Kaartinen et al., 1995; Proetzel et al., 1995; Sanford
t al., 1997). As endoglin is known to bind TGFb1 in
ssociation with TbRII (Barbara et al., 1999), the evidence
uggests that endoglin is required for TGFb1 signaling
uring extraembryonic angiogenesis. Many, although not
ll, of the eng2/2 embryos showed defects in haematopoi-
esis. Some of the variation seen in haematopoietic defects
may be due to the random segregation of alleles at multiple
Copyright © 2000 by Academic Press. All rightloci in the embryos, a common and often overlooked
problem affecting the examination of knockout mice in a
mixed genetic background. Endoglin is temporarily ex-
pressed in differentiating pro-erythrocytes in foetal and
adult bone marrow (Rokhlin et al., 1995) and this may
correspond to a parallel stage at which haematopoiesis may
stall in the yolk sac of endoglin-deficient 9.5 dpc embryos.
The gross defects described in the eng2/2 9.5 dpc embryos
are in the extraembryonic vasculature of the yolk sac, while
the embryonic vasculature, with the exception of the heart,
appears to form almost normally, indicating that there are
differences in the signaling pathways involved in the for-
mation of extraembryonic and embryonic vascular systems.
In contrast, the VEGF receptor flk-1 is required for both
pathways and its absence causes severe disorganisation of
vessels in both extraembryonic and embryonic tissue
(Shalaby et al., 1995).
Endoglin is expressed in endothelial cells throughout the
eveloping vascular system (Fig. 3A) in a strikingly similar
attern to that of avian TbRII expression at a similar stage
f development (Brown et al., 1996). Expression of endoglin
n mesenchymal cells of the endocardial cushion (Fig. 4G) is
lso seen in human tissue (Qu et al., 1998). As there is
bnormal truncal cushion formation in the eng2/2 embryos
(Figs. 3, and 4D), endoglin may also play a role as an
ancillary TGFb receptor during endocardial cushion forma-
tion. It is likely that TGFb1, as a ligand of both endoglin
and TbRII, is involved, as it too is expressed in the devel-
oping heart valve (Heine et al., 1987) and disorganised
valves have been reported for TGFb1 null mice developing
in the complete absence of circulating maternal TGFb1
(Letterio et al., 1994). The role of endoglin may relate to the
essential role recently shown for betaglycan in avian endo-
cardial cell transformation (Brown et al., 1999). Betaglycan
is a type III TGFb receptor, which shares a region of high
equence homology with endoglin in the cytoplasmic do-
ain (Lopez-Casillas et al., 1991), but unlike endoglin,
ugments TGFb2 signaling (Lopez-Casillas et al., 1993).
However, there are also some differences between endoglin
expression in developing heart tissue of chick and mouse
(Vincent et al., 1998), and further studies are required to
determine its role in heart development of both animals.
Endoglin expression remains high in adult mouse heart
valves, in agreement with previous reports (St-Jacques et
al., 1994), suggesting a continued role in this tissue. In
addition, the abnormal cardiac looping, enlarged cardiac
ventricles and pericardial sac and the particularly high
expression of endoglin in the endocardium in the 9.5 dpc
embryos provide evidence that endoglin has a more general
role to play during cardiogenesis. Transgenic expression of a
constitutively activated mutation of Alk5 in myocytes
severely disrupts cardiac looping (Charng et al., 1998) and it
is possible that loss of endoglin upsets the balance of
signaling between different receptor complexes of the TGFb
family expressed in endocardial cells leading to a similar
but less severe effect. However, as we observed significant
variation in the cardiac defects, which may have been due
s of reproduction in any form reserved.
A
a
t
t
v
s
e
s
52 Arthur et al.to random segregation of modifier alleles in the progeny, we
are now breeding the endoglin mutation into a number of
pure lines to reduce this problem and ultimately allow the
identification of modifier genes.
In the presence of a modifier allele on chromosome 5 of
the NIH strain, the defects in haematopoiesis and vasculo-
genesis of theTGFb1 knockout (KO) mice are suppressed
and they can progress to birth (Bonyadi et al., 1997).
However, they die at about 3 weeks from severe inflamma-
tory disease (Kulkarni et al., 1993; Shull et al., 1992). We
have now bred the endoglin mutation into the NIH back-
ground and have seen no rescue to birth of the lethal
phenotype of animals homozygous for the endoglin muta-
tion, suggesting that endoglin acts downstream of this
modifier.
There appear to be no deleterious effects of a single copy
of the endoglin mutation on longevity (the oldest eng1/2
mice are now aged 18 months) or fertility in the mixed (129
plus C57BL/6) genetic background. However, the fragile,
dilated, and convoluted vessels seen in occasional heterozy-
gous adults have to date only been observed in the 129/Ola
genetic background and it may be significant that this
strain has low levels of circulating TGFb1 (Rosemary
khurst, personal communication). It is not clear why, in
n isogenic background, only some individuals develop
hese abnormal vessels, but we intend to identify the
riggers that induce the vascular defects and thereby de-
elop a reliable model of HHT1.
In conclusion, we have shown that endoglin is indispen-
ible in early development and we propose that it is an
ssential component of the TGFb1 signaling pathway re-
quired for the formation of blood vessels in the yolk sac and
for normal cardiogenesis. This proposal does not concur
with data from in vitro experiments showing that endoglin
is not required for TGFb1 signaling and can even block
ome cellular responses to TGFb1, such as growth-arrest
(Lastres et al., 1996; Letamendı´a et al., 1998). A possible
explanation of these apparently contradictory data is that
endoglin is required for activation and/or release of TGFb1
from the extracellular matrix in vivo, in order to make it
available to the signaling receptors and this role is bypassed
in in vitro experiments when free, active TGFb1 is used.
Clearly, much remains to be learned about the role of
endoglin in vascular development and maintenance and we
are confident that the endoglin KO mouse will be an
invaluable tool for further studies.
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